Showing results (101-110 of 284) with videos related to
Sort By:
Pageof 29
Journal of Thrombosis and Haemostasis : JTH|February 4, 2009
Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in womenB M Everett, R J Glynn, J E Buring, et al.Atherosclerosis|December 2, 1999
Race and gender differences in cord blood lipoproteinsC M Loughrey, E Rimm, G Heiss, et al.Clinical Biochemistry|February 1, 1995
Prolonged survival in pyruvate carboxylase deficiency: lack of correlation with enzyme activity in cultured fibroblastsH J Stern, R Nayar, L Depalma, et al.Therapeutic Drug Monitoring|September 22, 2005
Tandem mass spectrometry method for the quantification of serum busulfanM D Kellogg, T Law, M Sakamoto, et al.Circulation|September 4, 1998
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy womenP M Ridker, J E Buring, J Shih, et al.Gastroenterology|April 1, 1985
Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplementsP M Ridker, S Ohkuma, W V McDermott, et al.Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysisR Y L Zee, H H Hegener, N R Cook, et al.Atherosclerosis|March 21, 2001
A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarctionR Y Zee, K Lindpaintner, B Struk, et al.Annals of Internal Medicine|October 16, 1999
Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in womenP M Ridker, C H Hennekens, J E Buring, et al.Lancet (London, England)|February 8, 1997
PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosisP M Ridker, C H Hennekens, C Schmitz, et al.Pageof 29